• Health & Medicine
• Science & Technology

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference. Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer, according to findings presented at the ESMO conference.

19 September 2021

• For Researchers
• Science & Technology

How cancer hijacks cell death: a new view of metastasis

Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance. Professor Jody Rosenblatt tells us why dysregulated cell death could have an impact not only on metastasis, but also therapy resistance.

17 September 2021

• Personal Stories

Coronavirus reports – Part 10: “I didn’t see my mum before I went into surgery”

This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones. This Childhood Cancer Awareness Month, we caught up with families who have been affected by children’s and young people’s cancers to find out how COVID-19 has impacted them and their loved ones.

15 September 2021

• Health & Medicine

New chemotherapy-free treatment for bowel cancer made available in Scotland

Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.   Pembrolizumab will be made available for some adults in Scotland with bowel cancer that’s spread to other parts of the body.  

14 September 2021

• Health & Medicine

Hormone therapy gets green light for advanced prostate cancer

Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option. Adults in England with advanced hormone-sensitive prostate cancer that’s spread to other parts of the body will now have a new treatment option.

14 September 2021

• Science & Technology

The Galleri multi-cancer blood test: What you need to know

There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test. There has been a lot of excitement about the Galleri test, and it’s obvious to see why. Here are three things you need to about this multi-cancer blood test.

13 September 2021

• Health & Medicine

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer. The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

10 September 2021

• Science & Technology

Thinking outside the box to tackle an aggressive children’s cancer

How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers. How our partnership with Children with Cancer UK is helping to transform our understanding of children’s and young people’s cancers.

8 September 2021

• For Researchers

Speaking a thousand words – how a cancer image collection is set to improve AI diagnosis

Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection Find out how the OPTIMAM project’s mammogram collection is heralding a new dawn of machine learning based cancer detection

8 September 2021

• For Supporters

Philanthropist Simon Collins: "I realised I could make a difference by applying things I can do to things I couldn't in a million years"

As chair of our philanthropic giving circle the Catalyst Club, businessman Simon Collins is helping to unlock transformational funding to support our life-saving research. Meet Simon and learn more about the Catalyst Club, which turns 10 this year. As chair of our philanthropic giving circle the Catalyst Club, businessman Simon Collins is helping to unlock transformational funding to support our life-saving research. Meet Simon and learn more about the Catalyst Club, which turns 10 this year.

6 September 2021

• For Researchers

Kinder and more effective - why childhood cancers need specific treatments

Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments. Dr Sally George tells us about her work on neuroblastoma and why childhood cancers really do need specific research to develop the most effective treatments.

3 September 2021